GENE | BPD (n=10) | MDD (n=13) | p valueA
| η2 |
---|
APP
| 7.63E-01± 4.80E-02 | 5.98E-01 ± 4.33E-02 | 0.006 | 0.303 |
CREB1
| 7.40E-01 ± 4.75E-02 | 6.39E-01 ± 2.15E-02 | 0.028 | 0.210 |
NFKB1
| 5.81E-01 ± 2.42E-02 | 5.29E-01 ± 1.99E-02 | 0.038 | 0.179 |
NR3C1
| 3.27E-01 ± 2.81E-02 | 2.78E-01 ± 9.51E-03 | 0.043 | 0.191 |
SPARC
| 3.20E+00 ± 2.72E-01 | 2.29E+00 ± 1.80E-01 | 0.003 | 0.300 |
TNF
| 1.36E-01 ± 5.99E-03 | 1.68E-01 ± 1.14E-02 | 0.032 | 0.200 |
- Raw data is displayed in the table. Expressed in scientific notation units where E+00 = x1, E-01 = x0.1, E-02 = x0.01, etc. Data were log transformed prior to analysis.
-
ABPD vs. MDD using 5 factor regression model with inclusion of age, QIDS-SR, anticonvulsant use, and antidepressant/antipsychotic use. Model has 23 patients, 5 variables, results in 17 degrees of freedom.
- p value is for effect of Diagnostic subgroup after adjusting for the effects of the other 4 factors.
- Effect sizes using η2 for where diagnostic subgroup was significant in the regression model were consistently large (>0.14).